Content about nicotine

April 1, 2013

GlaxoSmithKline Consumer Healthcare today commended the proposals by the U.S. Food and Drug Administration after the administration announced recommendations to remove certain warning statements and modifications of the instructions for use of nicotine replacement therapy products.

PARSIPPANY, N.J. — GlaxoSmithKline Consumer Healthcare today commended the proposals by the U.S. Food and Drug Administration after the administration announced recommendations to remove certain warning statements and modifications of the instructions for use of nicotine replacement therapy products.

According to the statement released by GSK Consumer Healthcare:

February 28, 2013

The number of adult smokers who had used electronic cigarettes more than doubled in the space of a year, according to a new study by the Centers for Disease Control and Prevention.

ATLANTA — The number of adult smokers who had used electronic cigarettes more than doubled in the space of a year, according to a new study by the Centers for Disease Control and Prevention.

February 21, 2013

Smokeless tobacco users who said they didn’t want to quit changed their minds or significantly cut back when given nicotine lozenges or tobacco-free snuff in a Mayo Clinic study.

ROCHESTER, Minn. — Smokeless tobacco users who said they didn’t want to quit changed their minds or significantly cut back when given nicotine lozenges or tobacco-free snuff in a Mayo Clinic study.

The findings are published in the February issue of Addictive Behaviors.

February 14, 2013

Safeway pharmacists will use a program developed by the University of California San Francisco School of Pharmacy to help people quit smoking, under a partnership with the supermarket operator announced by the university.

NEW YORK — Safeway pharmacists will use a program developed by the University of California San Francisco School of Pharmacy to help people quit smoking, under a partnership with the supermarket operator announced by the university.

Safeway pharmacists will receive training in smoking-cessation counseling techniques developed by the UCSF pharmacy faculty, while stores will locate OTC nicotine-replacement therapies near pharmacy areas, giving customers convenient access to the pharmacist.

January 23, 2013

Cytos Biotechnology will regain rights to an experimental vaccine against nicotine addiction that it had licensed to Novartis, Cytos said Wednesday.

SCHLIEREN, Switzerland — Cytos Biotechnology will regain rights to an experimental vaccine against nicotine addiction that it had licensed to Novartis, Cytos said Wednesday.

The company said that Novartis would discontinue the project, known as NIC002. Cytos granted Novartis a license for NIC002 in 2007, but phase-2 trial results in October 2009 indicated that the vaccine spurred the development of nicotine-specific antibodies in patients, but did not increase smoking cessation.

January 22, 2013

Perrigo announced that it has begun shipments of over-the-counter nicotine polacrilex mini lozenge USP, 2 mg (mint flavor) and 4 mg (mint flavor), comparable to GlaxoSmithKline's Nicorette mini lozenge.

ALLEGAN, Mich. — Perrigo on Tuesday announced that it has begun shipments of over-the-counter nicotine polacrilex mini lozenge USP, 2 mg (mint flavor) and 4 mg (mint flavor), comparable to GlaxoSmithKline's Nicorette mini lozenge. 

"This launch strengthens Perrigo's leading store brand position in smoking cessation products, which also includes coated and uncoated flavored gums and regular size lozenges," stated Joseph Papa, Perrigo's chairman, president and CEO. 

January 8, 2013

New results from a national online public opinion poll of Americans 18 and older show that 34% of smokers plan to quit smoking as a New Year’s resolution in 2013, as compared to only 18% who reported that quitting smoking was a New Year’s resolution in 2012.

WASHINGTON — New results from a national online public opinion poll of Americans 18 and older show that 34% of smokers plan to quit smoking as a New Year’s resolution in 2013, as compared to only 18% who reported that quitting smoking was a New Year’s resolution in 2012. Increasing costs of cigarettes (67%) and concerns about the health risks associated with smoking (58%) were two of the key factors motivating smokers to contemplate quitting as a resolution for 2013.

January 4, 2013

Sales of smoking cessation aids are projected to reach $1 billion in 2012 with continued growth driving sales as high as $1.2 billion by 2017, market research firm Mintel reported.

CHICAGO — Sales of smoking cessation aids are projected to reach $1 billion in 2012 with continued growth driving sales as high as $1.2 billion by 2017, market research firm Mintel reported Thursday. 

December 17, 2012

The consumer products division of British drug maker GlaxoSmithKline wants its voice heard at a Food and Drug Administration hearing scheduled for next year on a section in a 2009 law to regulate tobacco products that deals with smoking-cessation products, the company said Monday.

PARSIPPANY, N.J. — The consumer products division of British drug maker GlaxoSmithKline wants its voice heard at a Food and Drug Administration hearing scheduled for next year on a section in a 2009 law to regulate tobacco products that deals with smoking-cessation products, the company said Monday.

December 11, 2012

The consumer healthcare division of drug maker GlaxoSmithKline has launched a new website designed to encourage people to quit smoking and promote such products as nicotine gums, lozenges and patches.

PARSIPPANY, N.J. — The consumer healthcare division of drug maker GlaxoSmithKline has launched a new website designed to encourage people to quit smoking and promote such products as nicotine gums, lozenges and patches.

Quit.com is described as a "total quit-smoking online resource" that includes features to help smokers create personalized plans for quitting without relapsing.

November 14, 2012

Rocasuba on Wednesday launched a homeopathic energy-booster utilizing a unique patch delivery system. Providing up to five hours of energy, the product delivers homeopathic ingredients, including naturally derived caffeine, tea extract and zinc.

MASHPEE, Mass. — Rocasuba on Wednesday launched a homeopathic energy-booster utilizing a unique patch delivery system. Providing up to five hours of energy, the product delivers homeopathic ingredients, including naturally derived caffeine, tea extract and zinc.

October 31, 2012

Watson Pharmaceuticals on Wednesday announced the sale of its Rugby over-the-counter business to the Harvard Drug Group — a distributor and provider of private-label OTCs and generic prescription products under the Major Pharmaceuticals brand — for approximately $117 million.

PARSIPPANY, N.J. — Watson Pharmaceuticals on Wednesday announced the sale of its Rugby over-the-counter business to the Harvard Drug Group — a distributor and provider of private-label OTCs and generic prescription products under the Major Pharmaceuticals brand — for approximately $117 million.  

"I am confident that Major, with its leadership position as a marketer of OTC products, will be more strategically positioned to maximize the value of the long-known and respected Rugby name," stated Paul Bisaro, president and CEO of Watson.

October 19, 2012

Smokers who have been unsuccessful to date in trying to kick the nicotine habit may be able to stop smoking by combining two smoking cessation approaches, according to a report published in the Oct. 17 issue of JAMA.

BOSTON — Smokers who have been unsuccessful to date in trying to kick the nicotine habit may be able to stop smoking by combining two smoking cessation approaches, according to a report published in the Oct. 17 issue of JAMA.  

October 12, 2012

The Food and Drug Administration took the Family Smoking Prevention and Tobacco Control Act of 2009 one step closer to being considered by the Supreme Court earlier this week.

 SILVER SPRING, Md. — The Food and Drug Administration took the Family Smoking Prevention and Tobacco Control Act of 2009 one step closer to being considered by the Supreme Court earlier this week. The FDA recently petitioned the D.C. Circuit Court of Appeals to revisit the court's August decision that ruled in favor of the tobacco industry and precluded the FDA from mandating that graphic images depicting the consequences of smoking be placed on all cigarette packaging. 

October 10, 2012

Perrigo on Wednesday announced that it has received approval from the Food and Drug Administration for its abbreviated new drug applications to market over-the-counter nicotine polacrilex mini lozenge USP in both 2-mg and 4-mg strengths.

ALLEGAN, Mich. — Perrigo on Wednesday announced that it has received approval from the Food and Drug Administration for its abbreviated new drug applications to market over-the-counter nicotine polacrilex mini lozenge USP in both 2-mg and 4-mg strengths. 

The mint-flavored mini lozenge is comparable with GlaxoSmithKline's Nicorette Mini Lozenge and is indicated to reduce withdrawal symptoms, including nicotine craving, associated with quitting smoking.

August 16, 2012

Global sales of nicotine replacement products are expected to reach $6.2 billion in 2018, following compound annual growth rates of 4.5% between now and then, GBI Research reported Wednesday.

NEW YORK — Global sales of nicotine replacement products are expected to reach $6.2 billion in 2018, following compound annual growth rates of 4.5% between now and then, GBI Research reported Wednesday.

April 17, 2012

Electronic cigarettes, sometimes called personal vaporizers, are making their way into the drug channel. As tobacco smoking in public is steadily becoming a thing of the past, smokers are looking for alternatives, and more retail channels are carrying the products.

Electronic cigarettes, sometimes called personal vaporizers, are making their way into the drug channel. As tobacco smoking in public is steadily becoming a thing of the past, smokers are looking for alternatives, and more retail channels are carrying the products.

Rite Aid has begun to carry several models of electronic cigarettes, replacement batteries and replacement cartridges, and is merchandising the products at the checkout near tobacco products.

April 3, 2012

Vapor recently expanded its e-cigarette offerings across its Krave brand.

HALLANDALE, Fla. — Vapor recently expanded its e-cigarette offerings across its Krave brand.

The company has constructed a complete retail-rack-ready, rechargeable e-cigarette program for its vendors of Krave1000 and Krave1001. The e-cigarettes are available in four versions featuring a high/low nicotine level option and tobacco and menthol flavors, along with starter kits and charger accessories.

March 30, 2012

GlaxoSmithKline Consumer Healthcare strongly supported efforts to inform smokers of the impact tobacco use has on the body, as well as effective ways to quit, during a congressional briefing Friday that was sponsored by Reps. Frank Pallone, D-N.J., and Tim Murphy, R-Pa.

PARSIPPANY, N.J. — GlaxoSmithKline Consumer Healthcare strongly supported efforts to inform smokers of the impact tobacco use has on the body, as well as effective ways to quit, during a congressional briefing Friday that was sponsored by Reps. Frank Pallone, D-N.J., and Tim Murphy, R-Pa.

The briefing, entitled "Understanding Smoking Addiction and How to Accelerate Quitting," addressed how to improve the nation's policies and programs to help smokers become tobacco free.

January 10, 2012

Nicotine replacement therapies designed to help people stop smoking, specifically nicotine patches and nicotine gum, do not appear to be effective in helping smokers quit long-term, even when combined with smoking-cessation counseling, according to a new survey by researchers at Harvard School of Public Health and the University of Massachusetts Boston posted in an advance online edition of Tobacco Control Monday.

BOSTON — Nicotine replacement therapies designed to help people stop smoking, specifically nicotine patches and nicotine gum, do not appear to be effective in helping smokers quit long-term, even when combined with smoking-cessation counseling, according to a new survey by researchers at Harvard School of Public Health and the University of Massachusetts Boston posted in an advance online edition of Tobacco Control Monday.

January 3, 2012

Geisinger Health System may be the largest employer to discriminate against a declining minority — smokers — beginning Feb. 1.

DANVILLE, Pa. — Geisinger Health System may be the largest employer to discriminate against a declining minority — smokers — beginning Feb. 1.

Geisinger last week announced it will no longer hire job applicants who use tobacco products, including cigarettes, cigars and chewing or smokeless tobacco.

November 21, 2011

Almost one-third of Americans who have not had enough money to pay for health care and/or medicine in the past 12 months are smokers, according to the October 2011 Gallup-Healthways Well-Being Index.

NASHVILLE, Tenn. — Almost one-third of Americans who have not had enough money to pay for health care and/or medicine in the past 12 months are smokers, according to the October 2011 Gallup-Healthways Well-Being Index. The percentage of smokers is cut in half (14.2%) when it comes to the population that can afford to pay for health care and/or medicine in the past 12 months. Of the Americans without a personal doctor, 27.5% smoke.

August 31, 2011

Star Scientific on Tuesday launched Anatabloc, a dietary supplement formulated to support the immune system.

GLEN ALLEN, Va. — Star Scientific on Tuesday launched Anatabloc, a dietary supplement formulated to support the immune system.

Anatabloc contains the dietary ingredient anatabine citrate, an alkaloid found in a variety of plants in the Solanaceae family, including the tobacco plant, as well as in eggplant, green peppers and green tomatoes. Anatabine citrate, combined with vitamins A and D3, is believed to assist the body in maintaining anti-inflammatory support, the company stated.

August 17, 2011

Perrigo is planning to launch more than 45 new products in fiscal 2012 that will translate into approximately $190 million added to annual Perrigo sales, Perrigo chairman, president and CEO Joe Papa told analysts during the company's fourth-quarter conference call Tuesday.

ALLEGAN, Mich. — Perrigo is planning to launch more than 45 new products in fiscal 2012 that will translate into approximately $190 million added to annual Perrigo sales, Perrigo chairman, president and CEO Joe Papa told analysts during the company's fourth-quarter conference call Tuesday.

And while none of these new over-the-counter private-label products will help reduce cholesterol levels, Papa did set the stage for a future store-brand equivalent to Pfizer's blockbuster statin Lipitor.

July 28, 2011

Almost half of all smokers try and fail to quit their addiction to nicotine products each year, according to a study released Wednesday.

PARSIPPANY, N.J. — Almost half of all smokers try and fail to quit their addiction to nicotine products each year, according to a study released Wednesday.

A contributing factor to the high rate of failed quit attempts is the low use of nicotine-replacement therapies, the study found. That may be because of misperceptions around the health effects of NRTs.